Should you buy Viatris stock now?
Yes, the technical signal for Viatris is currently BUY. Viatris trades at $17.11 as of 8/6/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 0.363 with rising momentum (signal: 0.362); RSI is at 59.8 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $17.94 points to 4.9% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Viatris stock?
The average analyst price target for Viatris is $17.94. The current price is $17.11, which gives an upside of 4.9%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $16.15 and $19.73.
Is Viatris a dividend stock?
Yes, Viatris is a dividend stock with a dividend yield of 2.72%. The latest dividend was $0.12 per share. The latest ex-dividend date (traded without the dividend) was 8/21/2026. The payout ratio is 26.2%, which is considered sustainable. The next dividend payment is scheduled for 6/17/2026.
When does Viatris pay a dividend in 2026?
Viatris pays its next dividend on 6/17/2026. The latest dividend was $0.12 per share with an ex-dividend date of 8/21/2026. The dividend yield is 2.72%. The payout ratio of 26.2% points to a sustainable dividend with room to grow.
What is the risk of Viatris stock?
Viatris is rated as a stock with moderately low risk. the annual standard deviation is 32.3%, which classifies the stock as moderately low risk.
Is Viatris overvalued?
Viatris is considered fairly valued – the price is close to the analyst price target. Viatris has the following valuation ratios: a P/S ratio of 1.4, a P/B ratio of 1.4. The stock trades close to the analyst price target and is considered fairly valued.
Is Viatris overbought?
No, Viatris is not overbought. RSI is at 59.8 (neutral zone). The technical indicators show: RSI is at 59.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.7% below the 20-day average (short-term downtrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Viatris earnings report?
Viatris reports earnings TODAY, August 6, 2026! The stock currently trades at $17.11. Watch how the price reacts after the release.
Is Viatris shorted?
Yes, Viatris is shorted with 4.1% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying Viatris stock?
No, insiders are not buying Viatris shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 1 sales. On a net basis, 809,729 $ worth of shares were sold. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 11,451,671 $ sold. Active sellers include Campbell Paul, Le Goff Corinne, Paul Campbell and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Viatris a good stock?
Based on our total score, Viatris is rated as a mediocre stock with a total score of 57 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 42/100, Quality: 37/100, Momentum: 93/100. In addition: a dividend of 2.72%; technical signal: Strong Buy. Whether Viatris is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Viatris stock?
The outlook for Viatris based on current data: the average analyst price target is $17.94 (+4.9%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 8/6/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Viatris stock moving?
Viatris is stable right now. The technical indicators show: the price is close to the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Viatris go?
The average analyst price target for Viatris is $17.94, which corresponds to a potential gain of 4.9% from the current price of $17.11. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Viatris fall?
We lack enough history to give a specific floor for Viatris. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Viatris do?
Viatris Inc. er et globalt sundhedsfirma, der driver forretning i fire hovedområder: Udviklede Markeder, Storkina, JANZ og Vækstmarkeder. De tjener primært penge på at sælge receptpligtig medicin, generiske lægemidler og biosimilære produkter. Viatris laver lægemidler inden fo... The company belongs to the Sundhed sector, more specifically the Drug Manufacturers - Specialty & Generic industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Viatris as an investment.
Did Viatris raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Viatris. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Viatris making money or losing money?
No, Viatris is currently not making money — the company is losing money with a negative profit margin of -2.0%, a small loss. That means the business loses money on every dollar of revenue. The operating margin, however, is positive at 6.8% — the core business makes money; the loss comes from financing costs, taxes or one-off items. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Viatris go bankrupt?
The bankruptcy risk of Viatris is rated as moderate. Altman Z2 (a model for assessing financial distress) is 1.36 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 123% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Viatris have a lot of debt?
Viatris has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 123%. For the sundhed sector, 80-150% counts as a typical level. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Viatris service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is -0.3x, and net debt equals 3.0 years of earnings (EBITDA).
